Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Deloitte
Fish and Richardson
Boehringer Ingelheim
Moodys
Accenture
QuintilesIMS
Citi
Cerilliant

Generated: January 23, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Gantenerumab

« Back to Dashboard

US Patents for Gantenerumab

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Gantenerumab ➤ Try a Free Trial Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded therapeutic protein CureVac AG (Tubingen, DE) ➤ Try a Free Trial
Gantenerumab ➤ Try a Free Trial Treatment of tauopathies Intellect Neurosciences Inc. (New York, NY) ➤ Try a Free Trial
Gantenerumab ➤ Try a Free Trial Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded therapeutic protein CureVac AG (Tubingen, DE) ➤ Try a Free Trial
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Gantenerumab

Drugname Country Document Number Estimated Expiration Related US Patent
Gantenerumab Canada 2826286 2031-01-31 ➤ Try a Free Trial
Gantenerumab European Patent Office 2670434 2031-01-31 ➤ Try a Free Trial
Gantenerumab World Intellectual Property Organization (WIPO) 2012106363 2031-01-31 ➤ Try a Free Trial
Gantenerumab Australia 2013220749 2032-02-15 ➤ Try a Free Trial
Gantenerumab Brazil 112014019627 2032-02-15 ➤ Try a Free Trial
Gantenerumab Canada 2862476 2032-02-15 ➤ Try a Free Trial
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Cerilliant
Federal Trade Commission
QuintilesIMS
US Army
Chinese Patent Office
Covington
Teva
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.